health pharma news today obesity drugs glp-1 Telehealth booms as demand for GLP-1s surges and questions mount about safety, oversight - MM+M A new oral GLP-1 option

NRF2 plays a critical role in this process by upregulating the expression of genes involved in the synthesis of -GC, thereby increasing the overall production of GSH [34]

We recommend the La Roche Posay Invisible Shaka Fluid SPF 50 because if can be used by all skin types

Enhanced Immune System Function Boosts Immune Cell Production : IGF-1 LR3 promotes the growth and repair of cells within the immune system, which can help improve immune response

The most frequent issues reported from the phase 3 studies are nausea (19%), fatigue (6%), skin darkening (4%), dizziness (4%), and the development of moles (4%)

WHO estimates that more than one billion people worldwide are living with obesity and warns that, without effective action, this figure could roughly double by 2030, contributing to millions of avoidable deaths each year (WHO, 2022, 2025a)